By Erin Duffy, chief scientific officer at Rib-X Pharmaceuticals, which uses knowledge of the bacterial ribosome to design new antibacterial drugs, 4:30 p.m., Brown Auditorium in Hale Laboratory. Sponsored by the Department of Chemistry.
This post was contributed by a community member. The views expressed here are the author's own.
The views expressed in this post are the author's own. Want to post on Patch?
